Andrew Jameson is an Infectious Disease physician affiliated with Trinity Health. OpenAlex indexes 52 publications with 210 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1900 44th St SE
Kentwood, MI 495085008
Telephone
616-685-8500Registry record last updated 13 Apr 2016.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20251 payment
- ABBVIE INC.Program year20241 payment
- AIMMUNE THERAPEUTICS, INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
94.2%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor16%Dovato55%Tivicay30%Cabenuva15%Part D<11 patientsPenicillins with extended spectrum9.2%Amoxicillin-Clavulanate Potass54%Amoxicillin46%Part D<11 patients+ 14 more classes in this area
Metabolism & gastrointestinal
3.2%Proton pump inhibitor3.2%Omeprazole100%Part D<11 patientsDermatology
2.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor2.6%Acyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cefdinir Versus Cephalexin for the Treatment of Uncomplicated Urinary Tract Infections
Open Forum Infectious Diseases
2025 - Evaluation of prescribing practices and treatment failure for purulent skin and soft tissue infections in patients with obesity
Antimicrobial Stewardship & Healthcare Epidemiology
2025 - Impact of a multifaceted intervention including supportive care order sentence implementation on outpatient antibiotic prescribing for upper respiratory tract infections
Antimicrobial Stewardship & Healthcare Epidemiology
2025 - Real-world Evaluation of Histoplasmosis Diagnosis and Treatment in Patients From a Michigan Health System
Open Forum Infectious Diseases
2025 - P-748. Evaluation of Risk Factors for Short Inpatient Hospital Stays for the Treatment of Cellulitis
Open Forum Infectious Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Zuwallack, MD
Trinity Health
James Figge, MD
Trinity Health
Bruno Digiovine, MD
Trinity Health
Mohammad Jazayeri, MD
Trinity Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”